News

Breast cancer survivors were less likely to get Alzheimer’s if they underwent this treatment: study
The number of Americans diagnosed with Alzheimer’s each year is expected to double by 2060, with the majority of cases affecting women.
Acumen Pharmaceuticals, Inc.: Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery ...
Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...